Clinical Trials
3
Active:0
Completed:2
Trial Phases
2 Phases
Phase 3:2
Phase 4:1
Drug Approvals
2
PHILIPPINES:2
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 3
2 (66.7%)Phase 4
1 (33.3%)Vaccine Prevention of Rabies Adopts 4-shot Immunization Method
Phase 3
Completed
- Conditions
- Antibody TiterRabies Human
- First Posted Date
- 2022-09-22
- Last Posted Date
- 2024-03-13
- Lead Sponsor
- Changchun Zhuoyi Biological Co., Ltd
- Target Recruit Count
- 1800
- Registration Number
- NCT05549908
- Locations
- 🇨🇳
Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China
Observation on the Immune Persistence of People Aged 10-60 Years Old Immunized With Five Doses of Rabies Vaccine
Phase 4
Completed
- Conditions
- AntibodyRabies
- First Posted Date
- 2022-09-21
- Last Posted Date
- 2022-09-21
- Lead Sponsor
- Changchun Zhuoyi Biological Co., Ltd
- Target Recruit Count
- 149
- Registration Number
- NCT05547815
- Locations
- 🇨🇳
Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China
Prevention of Rabies With Four Doses of Rabies Vaccine
Phase 3
- Conditions
- AntibodyRabies Human
- First Posted Date
- 2022-09-19
- Last Posted Date
- 2024-07-10
- Lead Sponsor
- Changchun Zhuoyi Biological Co., Ltd
- Target Recruit Count
- 2100
- Registration Number
- NCT05545371
- Locations
- 🇨🇳
Changchun Zhuoyi Biological Co., Ltd, Changchun, Jilin, China
News
No news found